Amgen Inc. (AMGN) Total liabilities 2016–2025
Amgen Inc. (AMGN) total liabilities at each fiscal year-end, per SEC filings.
$81.9BFY2025 · since FY2016: $47.8B → $81.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81.9B | -4.7% |
| FY2024 | $86.0B | -5.5% |
| FY2023 | $90.9B | +47.9% |
| FY2022 | $61.5B | +12.8% |
| FY2021 | $54.5B | +1.7% |
| FY2020 | $53.5B | +7.0% |
| FY2019 | $50.0B | -7.2% |
| FY2018 | $53.9B | -1.5% |
| FY2017 | $54.7B | +14.6% |
| FY2016 | $47.8B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN RevenueAMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating incomeAMGN Operating marginAMGN Operating cash flowAMGN Free cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Shareholders’ equityAMGN overview →